|
Market Closed -
Japan Exchange
12:00:00 21/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 81.00 JPY | -2.41% |
|
+2.53% | +3.85% |
| 13/08 | Ribomic Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 02/07 | Ribomic Enrolls First Patient in Phase III Trials of Umedaptanib Pegol for Achondroplasia Treatment | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.41% | +2.53% | +8.00% | +8.00% | +3.85% | -20.59% | -43.36% | -73.44% | -87.86% | 2.88Cr | |
| -3.00% | +2.27% | +29.36% | +56.63% | +79.68% | +73.26% | +109.90% | +32.41% | - | 7.21TCr | |
| +1.90% | +23.53% | +18.93% | +28.67% | +25.84% | +59.48% | +94.82% | +235.32% | +6,551.92% | 6.59TCr | |
| +5.12% | +25.22% | +26.94% | +26.51% | +22.45% | +5.13% | -5.86% | -66.57% | - | 2.93TCr | |
| +0.55% | +1.64% | +17.94% | +18.38% | -27.74% | -4.63% | +480.92% | +433.60% | +835.79% | 2.75TCr | |
| +2.74% | +12.98% | +31.31% | +55.87% | +62.21% | +54.92% | +25.77% | -51.57% | - | 2.67TCr | |
| +0.47% | +6.12% | +12.56% | +24.80% | +6.12% | +37.01% | -15.31% | -29.36% | +87.04% | 2.01TCr | |
| +1.82% | -6.67% | +18.64% | +91.73% | +230.42% | +251.36% | +388.91% | +1,862.87% | +913.76% | 1.82TCr | |
| +0.94% | +3.36% | +4.06% | +13.45% | +37.17% | +15.30% | +548.19% | - | - | 1.64TCr | |
| +0.73% | +5.54% | -1.64% | +7.84% | +23.39% | +39.99% | +151.77% | +193.28% | +372.73% | 1.34TCr | |
| -0.41% | +0.54% | -1.79% | +16.22% | +31.21% | +308.39% | +206.94% | +45.35% | +1,024.00% | 1.23TCr | |
| -0.45% | +1.81% | -3.89% | -0.10% | -11.26% | +24.61% | +185.67% | +541.75% | +5,444.42% | 1.19TCr | |
| -3.89% | -5.99% | -8.75% | -22.60% | -20.13% | -48.98% | +188.80% | +150.35% | - | 1.06TCr | |
| -0.44% | +3.66% | -6.51% | -0.13% | +20.93% | +100.42% | +130.34% | +151.44% | +531.39% | 1.07TCr | |
| +5.87% | -1.42% | -10.72% | -20.82% | -24.76% | -49.77% | +623.08% | +70.91% | +81.52% | 1.05TCr | |
| -1.21% | +2.76% | +7.38% | +43.81% | +225.06% | +512.72% | +720.73% | -39.24% | -24.48% | 938.96Cr | |
| -1.25% | -2.23% | -8.04% | -6.96% | +9.58% | -2.71% | +125.11% | -16.95% | - | 869.63Cr | |
| +2.09% | +7.84% | +11.82% | +32.39% | +35.72% | +93.93% | +26.74% | +192.21% | - | 931.82Cr | |
| 0.00% | -0.01% | +1.16% | +130.14% | +81.93% | +173.90% | +387.28% | +305.80% | - | 898.27Cr | |
| -0.64% | +2.91% | +3.73% | +7.89% | +293.43% | +237.23% | +358.24% | -22.10% | - | 825.61Cr | |
| Average | +0.43% | +4.38% | +7.52% | +25.59% | +55.26% | +93.05% | +234.43% | +206.11% | +1,430.02% | 1.95TCr | |
| Weighted average by Cap. | +0.54% | +7.27% | +15.19% | +32.97% | +51.09% | +77.15% | +192.05% | +206.48% | +2,810.76% |
- Stock Market
- Stocks
- 4591 Stock
- Sector Ribomic Inc.
Select your edition
All financial news and data tailored to specific country editions
